Development and validation of a HPLC electrochemical detection method to measure COMT activity as a tool in drug development

Autor: Viljoen, F.P., Du Preez, J.L., Petzer, A., Wessels, J.C., Petzer, J.
Přispěvatelé: 11775416 - Viljoen, Francois Petrus, 10060510 - Du Preez, Jan Lourens, 12264954 - Petzer, Anél, 10727388 - Petzer, Jacobus Petrus, 10204040 - Wessels, Johanna Christina
Jazyk: angličtina
Rok vydání: 2019
Popis: The determination of catechol-O-methyltransferase (COMT) activity is considered valuable for various pharmaceutical and biomedical research projects. A specific high performance liquid chromatography-coulometric electrochemical detection method, for the assay of COMT activity was developed by measuring the formation of normetanephrine from norepinephrine. The chromatographic separation was achieved on a C18 reversed phase column with a mobile phase consisting of 10 mM sodium dihydrogen phosphate buffer, 4 mM sodium 1-octanesulfonate, 0.17 mM ethylenediaminetetra-acetic acid disodium salt, 6 % methanol and 4 % acetonitrile (pH ± 4.0). The detection of normetanephrine was achieved through electrochemical detection, with a coulometric cell potential setting of +450 mV. The flow rate was at 1 ml/min and the total run time was 45 min. The method was validated according to validation guidelines (Shabir 2006; European Medicines Agency 2011; US FDA 2018). The method was found to be linear (R2 > 0.99) over the analytical range (100 to 2500 ng/ml) for all the analytes. All the other validation parameters (sensitivity, precision, accuracy, recovery and stability) were acceptable and within range. The method was applied for the determination of COMT activity in rat liver homogenate test samples. The known selective COMT inhibitor entacapone was used as test inhibitor. The results confirmed the ability of entacapone to inhibit COMT activity by decreasing the production of all the metabolites of norepinephrine
Databáze: OpenAIRE